Howe & Rusling Inc Ligand Pharmaceuticals Inc Transaction History

Howe & Rusling Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$99.52 - $215.83 $2,985 - $6,474	-30 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$80.55 - $106.05 $1,047 - $1,378	13 Added 76.47%	30 $3,000
Q2 2020 Jul 15, 2020	BUY	$68.28 - $123.65 $1,160 - $2,102	17 New	17 $2,000
Q1 2019 Apr 29, 2019	SELL	$105.93 - $142.47 $3,389 - $4,559	-32 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$211.18 - $274.49 $6,757 - $8,783	32 New	32 $9,000

Q2 2018 Jul 31, 2018	SELL	$150.77 - $207.98 $201,277 - $277,653	-1,335 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$120.91 - $137.94 $161,414 - $184,149	1,335	1,335 $182,000

233

16.5M

77.9K

25K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.42B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.